Xiangyu Medical Co. Ltd. A (688626) — Cash Flow Reinvestment Rate
Xiangyu Medical Co. Ltd. A (688626) has a Cash Flow Reinvestment Rate of 3.23x as of September 2025, reinvesting CN¥58.35 Million (capex CN¥58.35 Million ) from operating cash flow of CN¥18.05 Million. See 688626 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Xiangyu Medical Co. Ltd. A Cash Flow Reinvestment Rate (2017–2024)
Historical reinvestment intensity for Xiangyu Medical Co. Ltd. A across 8 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Xiangyu Medical Co. Ltd. A.
Annual Cash Flow Reinvestment Rate for Xiangyu Medical Co. Ltd. A (2017–2024)
Year-by-year capital reinvestment analysis for Xiangyu Medical Co. Ltd. A. See Xiangyu Medical Co. Ltd. A (688626) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.46x | CN¥439.95 Million | CN¥178.59 Million | CN¥438.89 Million | ▼ -21.3% |
| 2023 | 3.13x | CN¥713.80 Million | CN¥227.91 Million | CN¥479.26 Million | ▲ +53.1% |
| 2022 | 2.05x | CN¥381.98 Million | CN¥186.70 Million | CN¥203.07 Million | ▼ -62.9% |
| 2021 | 5.52x | CN¥915.95 Million | CN¥165.88 Million | CN¥133.91 Million | ▲ +328.1% |
| 2020 | 1.29x | CN¥279.12 Million | CN¥216.40 Million | CN¥139.71 Million | ▼ -4.3% |
| 2019 | 1.35x | CN¥210.20 Million | CN¥155.94 Million | CN¥21.07 Million | ▲ +1325.5% |
| 2018 | 0.09x | CN¥7.02 Million | CN¥74.20 Million | CN¥7.02 Million | ▼ -62.2% |
| 2017 | 0.25x | CN¥14.84 Million | CN¥59.31 Million | CN¥14.84 Million | — |